313 related articles for article (PubMed ID: 12933827)
21. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection.
Feldmesser M; Kress Y; Novikoff P; Casadevall A
Infect Immun; 2000 Jul; 68(7):4225-37. PubMed ID: 10858240
[TBL] [Abstract][Full Text] [Related]
22. Phospholipids trigger Cryptococcus neoformans capsular enlargement during interactions with amoebae and macrophages.
Chrisman CJ; Albuquerque P; Guimaraes AJ; Nieves E; Casadevall A
PLoS Pathog; 2011 May; 7(5):e1002047. PubMed ID: 21637814
[TBL] [Abstract][Full Text] [Related]
23. The environmental yeast Cryptococcus liquefaciens produces capsular and secreted polysaccharides with similar pathogenic properties to those of C. neoformans.
Araújo GRS; Freitas GJC; Fonseca FL; Leite PEC; Rocha GM; de Souza W; Santos DA; Frases S
Sci Rep; 2017 Apr; 7():46768. PubMed ID: 28440301
[TBL] [Abstract][Full Text] [Related]
24. Dictyostelium discoideum as a model to study host-pathogen interactions.
Unal C; Steinert M
Methods Mol Biol; 2006; 346():507-15. PubMed ID: 16957311
[TBL] [Abstract][Full Text] [Related]
25. Decreased virulence in stable, acapsular mutants of cryptococcus neoformans.
Fromtling RA; Shadomy HJ; Jacobson ES
Mycopathologia; 1982 Jul; 79(1):23-9. PubMed ID: 6750405
[TBL] [Abstract][Full Text] [Related]
26. Dictyostelium discoideum: a new host model system for intracellular pathogens of the genus Legionella.
Hägele S; Köhler R; Merkert H; Schleicher M; Hacker J; Steinert M
Cell Microbiol; 2000 Apr; 2(2):165-71. PubMed ID: 11207573
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection.
Fries BC; Taborda CP; Serfass E; Casadevall A
J Clin Invest; 2001 Dec; 108(11):1639-48. PubMed ID: 11733559
[TBL] [Abstract][Full Text] [Related]
28. Characterization of pathogenic constituents of Cryptococcus neoformans strains.
Kagaya K; Yamada T; Miyakawa Y; Fukazawa Y; Saito S
Microbiol Immunol; 1985; 29(6):517-32. PubMed ID: 3900645
[TBL] [Abstract][Full Text] [Related]
29. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence.
Chang YC; Kwon-Chung KJ
Mol Cell Biol; 1994 Jul; 14(7):4912-9. PubMed ID: 8007987
[TBL] [Abstract][Full Text] [Related]
30. Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival.
Geunes-Boyer S; Oliver TN; Janbon G; Lodge JK; Heitman J; Perfect JR; Wright JR
Infect Immun; 2009 Jul; 77(7):2783-94. PubMed ID: 19451250
[TBL] [Abstract][Full Text] [Related]
31. Evaluating Different Virulence Traits of
Marcoleta AE; Varas MA; Ortiz-Severín J; Vásquez L; Berríos-Pastén C; Sabag AV; Chávez FP; Allende ML; Santiviago CA; Monasterio O; Lagos R
Front Cell Infect Microbiol; 2018; 8():30. PubMed ID: 29479519
[TBL] [Abstract][Full Text] [Related]
32. An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo.
Rachini A; Pietrella D; Lupo P; Torosantucci A; Chiani P; Bromuro C; Proietti C; Bistoni F; Cassone A; Vecchiarelli A
Infect Immun; 2007 Nov; 75(11):5085-94. PubMed ID: 17606600
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic switching in a Cryptococcus neoformans variety gattii strain is associated with changes in virulence and promotes dissemination to the central nervous system.
Jain N; Li L; McFadden DC; Banarjee U; Wang X; Cook E; Fries BC
Infect Immun; 2006 Feb; 74(2):896-903. PubMed ID: 16428732
[TBL] [Abstract][Full Text] [Related]
34. Induction of signal transduction pathways related to the pathogenicity of Cryptococcus neoformans in the host environment.
Matsumoto Y; Azami S; Shiga H; Nagamachi T; Moriyama H; Yamashita Y; Yoshikawa A; Sugita T
Drug Discov Ther; 2019; 13(4):177-182. PubMed ID: 31534068
[TBL] [Abstract][Full Text] [Related]
35. The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans.
Steenbergen JN; Casadevall A
Microbes Infect; 2003 Jun; 5(7):667-75. PubMed ID: 12787743
[TBL] [Abstract][Full Text] [Related]
36. Microevolution during serial mouse passage demonstrates FRE3 as a virulence adaptation gene in Cryptococcus neoformans.
Hu G; Chen SH; Qiu J; Bennett JE; Myers TG; Williamson PR
mBio; 2014 Apr; 5(2):e00941-14. PubMed ID: 24692633
[TBL] [Abstract][Full Text] [Related]
37. Interferon-γ promotes phagocytosis of Cryptococcus neoformans but not Cryptococcus gattii by murine macrophages.
Ikeda-Dantsuji Y; Ohno H; Tanabe K; Umeyama T; Ueno K; Nagi M; Yamagoe S; Kinjo Y; Miyazaki Y
J Infect Chemother; 2015 Dec; 21(12):831-6. PubMed ID: 26477011
[TBL] [Abstract][Full Text] [Related]
38. UDP-Glucuronic Acid Transport Is Required for Virulence of
Li LX; Rautengarten C; Heazlewood JL; Doering TL
mBio; 2018 Jan; 9(1):. PubMed ID: 29382737
[TBL] [Abstract][Full Text] [Related]
39. 'Ready made' virulence and 'dual use' virulence factors in pathogenic environmental fungi--the Cryptococcus neoformans paradigm.
Casadevall A; Steenbergen JN; Nosanchuk JD
Curr Opin Microbiol; 2003 Aug; 6(4):332-7. PubMed ID: 12941400
[TBL] [Abstract][Full Text] [Related]
40. Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form.
Cross CE; Bancroft GJ
Infect Immun; 1995 Jul; 63(7):2604-11. PubMed ID: 7790075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
